| scholarly article | Q13442814 |
| P2093 | author name string | Eleftheria P Tsagalou | |
| John N Nanas | |||
| Stavros G Drakos | |||
| John V Terrovitis | |||
| Maria Anastasiou-Nana | |||
| Argirios Ntalianis | |||
| Emmanuel Agapitos | |||
| Apostolia Gika | |||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| patient | Q181600 | ||
| P304 | page(s) | 1391-1398 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy | |
| P478 | volume | 52 |
| Q51334798 | Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction. |
| Q35437314 | Abnormalities of capillary microarchitecture in a rat model of coronary ischemic congestive heart failure |
| Q30619167 | Antifailure therapy including spironolactone improves left ventricular energy supply-demand relations in nonischemic dilated cardiomyopathy |
| Q55277742 | Cardiac-specific overexpression of aldehyde dehydrogenase 2 exacerbates cardiac remodeling in response to pressure overload. |
| Q30492863 | Cardiomyocyte PDGFR-beta signaling is an essential component of the mouse cardiac response to load-induced stress. |
| Q51014934 | Continuous-Flow Left Ventricular Assist Device Support Improves Myocardial Supply:Demand in Chronic Heart Failure. |
| Q37216087 | Coronary flow reserve from mouse to man--from mechanistic understanding to future interventions |
| Q47792905 | Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage. |
| Q46230060 | Coronary microvascular Kv1 channels as regulatory sensors of intracellular pyridine nucleotide redox potential. |
| Q35072520 | Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction |
| Q33967744 | Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. |
| Q53113411 | Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis. |
| Q34493878 | Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels |
| Q36836456 | Effects of Epicardial and Endocardial Cardiac Resynchronization Therapy on Coronary Flow: Insights From Wave Intensity Analysis. |
| Q33856656 | Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation. |
| Q53611731 | Fractional flow reserve derived from coronary computed tomography angiography: diagnostic performance in hypertensive and diabetic patients. |
| Q64057308 | Functional capillary impairment in patients with ventricular assist devices |
| Q41927822 | Human Parvovirus B19 (B19V) Up-regulates CXCR4 Surface Expression of Circulating Angiogenic Cells: Implications for Cardiac Ischemia in B19V Cardiomyopathy. |
| Q49668218 | Identification of capillary rarefaction using intracoronary wave intensity analysis with resultant prognostic implications for cardiac allograft patients |
| Q64059724 | Impaired myocardial perfusion is associated with increasing end-systolic- and end-diastolic volumes in patients with non-ischemic systolic heart failure: a cross-sectional study using Rubidium-82 PET/CT |
| Q37622037 | Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy |
| Q52598352 | Klf4 has an unexpected protective role in perivascular cells within the microvasculature. |
| Q37021783 | Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. |
| Q58703037 | MiR-665 aggravates heart failure via suppressing CD34-mediated coronary microvessel angiogenesis |
| Q93123451 | Model-based analysis of the sensitivities and diagnostic implications of FFR and CFR under various pathological conditions |
| Q36273415 | Myocardial blood flow assessment with 82rubidium-PET imaging in patients with left bundle branch block |
| Q38596113 | Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance. |
| Q37784376 | Myocardial ischemia in patients with dilated cardiomyopathy |
| Q42256339 | Notch3 deficiency impairs coronary microvascular maturation and reduces cardiac recovery after myocardial ischemia |
| Q90025681 | Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes |
| Q41068150 | Pediatric and adult dilated cardiomyopathy represent distinct pathological entities |
| Q38854987 | Physiological and pathological cardiac hypertrophy. |
| Q33397848 | Prenatal hypoxia induces increased cardiac contractility on a background of decreased capillary density |
| Q36252748 | Pressure-wire based assessment of microvascular resistance using calibrated upstream balloon obstruction: a predictor of myocardial viability |
| Q36117344 | Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes |
| Q53318187 | Reduction in coronary microvascular resistance through cardiac resynchronization and its impact on chronic reverse remodelling of left ventricle in patients with non-ischaemic cardiomyopathy. |
| Q37638903 | Regional mapping of myocardial hibernation phenotype in idiopathic end-stage dilated cardiomyopathy |
| Q47227141 | Sublingual functional capillary rarefaction in chronic heart failure |
| Q35535232 | Syndrome X and microvascular coronary dysfunction |
| Q64884869 | Takotsubo cardiomyopathy in two patients with microvascular angina. |
| Q39304682 | Targeting the dominant mechanism of coronary microvascular dysfunction with intracoronary physiology tests |
| Q36479962 | The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells |
| Q28076570 | The fibrosis-cell death axis in heart failure |
| Q57118740 | Timing of Left Ventricular Remodeling in Nonischemic Dilated Cardiomyopathy |
| Q34968274 | Traditional chinese medicine tongxinluo improves cardiac function of rats with dilated cardiomyopathy |
| Q38859398 | What is coronary blood flow reserve? Insights using myocardial contrast echocardiography |
| Q38722030 | β-adrenergic receptor signalling and its functional consequences in the diseased heart. |
Search more.